Lauren E. Cipriano

Dr. Lauren Cipriano is a Professor in Management Science at the Ivey Business School where she is the Canada Research Chair in Healthcare Analytics, Management, and Policy. She holds cross appointments in the Department of Medicine and the Department of Epidemiology and Biostatistics at the Schulich School of Medicine & Dentistry at Western University.

Dr. Cipriano specializes in applying statistics, decision analysis, economics, and operations research to health policy problems. Her research focuses on the economic evaluation of clinical diagnostics and innovative therapeutics, resource allocation, and infectious disease policy.

She has provided consulting services to prominent organizations including the World Health Organization, US Veterans Health Administration, US Centers for Medicare and Medicaid Services, the US Institute for Clinical and Economic Review, and Canada's Drug Agency (formerly, the Canadian Agency for Drugs and Technologies in Health (CADTH)). During the pandemic, Dr. Cipriano served on the Ontario COVID-19 Science Advisory Table’s Modelling Consensus Table.

Dr. Cipriano is an Investigator with the Toronto Health Economics and Technology Assessment (THETA) Collaborative and a Research Affiliate with the Center for Health Economics of Treatment Interventions for Substance Use Disorder, HCV, and HIV (CHERISH).  From 2019 to 2023, she served on the Health Economics Methods Advisory Committee for Canada's Drug Agency and was awarded the Dr. Maurice McGregor Award for Health Technology Assessment in 2019.

Dr. Cipriano is the Deputy Editor of the journals Medical Decision Making and MDM Policy & Practice.

Dr. Cipriano earned her MS in Statistics and PhD in Management Science and Engineering from Stanford University. She previously worked at the Institute for Technology Assessment at Massachusetts General Hospital.  

At Ivey, Dr. Cipriano teaches undergraduate Decision Making with Analytics and graduate courses in Business Analytics and Statistics.

Recent Publications

Ghamat S, Araghi M, Cipriano LE, Silverman M. Influencing primary care antibiotic prescription behavior using financial incentives. Production and Operations Management. 2024; 33(10): 2051—2072. [link]

Goldhaber-Fiebert JD, Cipriano LE. Pricing treatments cost-effectively when they have multiple indications: not just a simple threshold analysis.  Medical Decision Making. 2023 Oct-Nov;43(7-8):914-929. [link]

Cipriano LE, Haddara WMR, Zaric GS, Enns EA. Impact of university re-opening on total community COVID-19 burden. Plos One. 2021; 16(8):e0255782 [link]

Fairley M, Cipriano LE, Goldhaber-Fiebert JD.  Optimal allocation of research funds under a budget constraint.  Medical Decision Making. 2020; 40(6):797–814 [link]

Chehrazi N, Cipriano LE, Enns EA.  Dynamics of drug resistance: optimal control of an infectious disease. Operations Research.  2019; 67(3):619–650. [link]

Cipriano LE, Weber TA.  Population-level intervention and information-collection in dynamic healthcare policy. Health Care Management Science. 2018; 21(4):604–631. [link]

Cipriano LE, Goldhaber-Fiebert JD, Liu S, Weber TA.  Optimal information collection policies in a Markov decision process framework. Medical Decision Making. 2018; 38(7):797–809. [link]

Cipriano LE, Liu S, Shahzada KS, Holodniy M, Goldhaber-Fiebert JD.  Economically efficient hepatitis C virus treatment prioritization improves health outcomes. Medical Decision Making. 2018; 38(7): 849–865. [link]        

Cipriano LE, Zaric GS.  Cost-effectiveness of naloxone kits in secondary schools. Drug and Alcohol Dependence. 2018; 192:352–361. [link]

For a full list of publications, please see Google Scholar